How do you pay?

How to pay the least

From

$12.49 for 30 tablets delivered ($7.24 plus $5.25 shipping)

Generic felodipine from Cost Plus Drugs, by mail. Pick the strength on your label above for its own price.

  1. Make a free account on costplusdrugs.com. Ask your prescriber to send the prescription there, or Cost Plus Drugs can transfer it.Open Cost Plus Drugs 
  2. Order generic felodipine. It comes by mail.

Need it today? From $13.33 for 30 tablets at Walgreens with the free Optum Perks coupon. Show the free coupon there. It can’t be used with insurance.

Get the free Optum Perks coupon 

A regular generic has the same active ingredient as Plendil, and the FDA requires it to work the same way.

Compare every option

Question
Brand namePlendil
Authorized genericfelodipine
Regular genericfelodipine
What you’d pay
Not soldNo longer sold
Not soldNo longer sold
From$12.49for 30 tablets at Cost Plus Drugs, with shipping
Same as Plendil?
–
–
Same active ingredientFillers and dyes can differ

Brand nameNot sold

Plendil itself isn’t sold as a prescription anymore. Its generic versions, if any, are in the other tabs.

See the regular generic →

Authorized genericNot sold now

An authorized generic of Plendil was sold before, but it isn’t sold now. Ask your pharmacist whether a regular generic (felodipine) is available.

Source: FDA, updated October 30, 2026

Regular genericWhere to buy it

Pharmacies’ own cash prices for generic felodipine, lowest first.

Pick up in storeDelivered

From each pharmacy’s own site, read November 2, 2026. Confirm the price before you fill.

About these prices

Prices change, can differ by store and state, and may depend on the strength and how many you take. With insurance, ask what your plan charges; it can be less.

Regular genericWho makes it

8 companies sell a generic of Plendil that the FDA rates a substitute. A pharmacy fills whichever one it stocks. To get a certain maker, ask for it by name; most pharmacies can order it in a day or two.

  • Avet PharmaceuticalsER tablet 2.5 mg, 5 mg, 10 mg

    Has lactose · Has a dye: D&C Yellow No. 10

    Product page on avetpharma.com

    How it looks, what’s in it, NDCs

    2.5 mg Yellow, round, 11 mm, marked “I31”

    PackageNDC
    Bottle of 10023155-048-01

    5 mg Light yellow, round, 11 mm, marked “I32”

    PackageNDC
    Bottle of 10023155-049-01

    10 mg White, round, 11 mm, marked “I33”

    PackageNDC
    Bottle of 10023155-050-01

    Inactive ingredients: polyoxyl 40 hydrogenated castor oil, magnesium aluminum silicate, hypromellose 2208 (15000 mpa.s), lactose monohydrate, hydroxypropyl cellulose (1600000 wamw), sodium stearyl fumarate, hypromellose 2910 (5 mpa.s), titanium dioxide, polyethylene glycol 400, ferric oxide yellow, D&C Yellow No. 10

    FDA label

  • Carlsbad TechnologyTablet 2.5 mg, 5 mg, 10 mg

    Has lactose · Made by Yung Shin Pharmaceutical Industrial

    How it looks, what’s in it, NDCs

    2.5 mg White, round, 11 mm, marked “YSP / 211”

    PackageNDC
    Bottle of 10061442-431-01
    Bottle of 50061442-431-05

    5 mg Orange, round, 11 mm, marked “YSP / 210”

    PackageNDC
    Bottle of 10061442-432-01
    Bottle of 50061442-432-05

    10 mg Red, round, 11 mm, marked “YSP / 051”

    PackageNDC
    Bottle of 10061442-433-01
    Bottle of 50061442-433-05

    Inactive ingredients: lactose monohydrate, hydroxypropyl cellulose (110000 wamw), silicon dioxide, hypromellose 2208 (100 mpa.s), magnesium stearate, butylated hydroxyanisole, calcium phosphate, dibasic, anhydrous, polyethylene glycol 1000, titanium dioxide

    FDA label

  • Chartwell RXER tablet 2.5 mg, 5 mg, 10 mg

    Has lactose · Made by Pharmobedient Consulting

    How it looks, what’s in it, NDCs

    2.5 mg Yellow, round, 11 mm, marked “Y161”

    PackageNDC
    Bottle of 9062135-646-90

    5 mg Pink, round, 11 mm, marked “Y162”

    PackageNDC
    Bottle of 9062135-647-90

    10 mg Red, round, 11 mm, marked “Y163”

    PackageNDC
    Bottle of 9062135-648-90

    Inactive ingredients: anhydrous lactose, butylated hydroxyanisole, butylated hydroxytoluene, silicon dioxide, hypromellose, polyoxyl 40 hydrogenated castor oil, microcrystalline cellulose, povidone k30, sodium stearyl fumarate, ferrosoferric oxide, ferric oxide red, ferric oxide yellow, maltodextrin, medium-chain triglycerides, polydextrose, talc, titanium dioxide

    FDA label

  • Glenmark PharmaceuticalsER tablet 2.5 mg, 5 mg, 10 mg

    Has lactose · Has dyes: D&C Yellow No. 10, FD&C Blue No. 2

    Product page on glenmarkpharma-us.com

    How it looks, what’s in it, NDCs

    2.5 mg Green, round, 11 mm, marked “G19 / plain”

    PackageNDC
    Bottle of 9068462-233-90
    Bottle of 10068462-233-01
    Carton of 10068462-233-11
    Bottle of 100068462-233-10

    5 mg Pink, round, 11 mm, marked “G19 / 5”

    PackageNDC
    Bottle of 9068462-234-90
    Bottle of 10068462-234-01
    Carton of 10068462-234-11
    Bottle of 100068462-234-10

    10 mg Brown, round, 11 mm, marked “G19 / 10”

    PackageNDC
    Bottle of 9068462-235-90
    Bottle of 10068462-235-01
    Carton of 10068462-235-11
    Bottle of 100068462-235-10

    Inactive ingredients: hydroxypropyl cellulose, hypromellose, kaolin, lactose monohydrate, microcrystalline cellulose, polyoxyl 40 hydrogenated castor oil, sodium stearyl fumarate, polyethylene glycol, titanium dioxide, D&C Yellow No. 10, FD&C Blue No. 2, ferric oxide yellow, ferric oxide red

    FDA label

  • Par HealthER tablet 2.5 mg, 5 mg, 10 mg

    Has lactose · Has a dye: FD&C Blue No. 2 · Made by PH Health

    How it looks, what’s in it, NDCs

    2.5 mg Green, round, 11 mm, marked “E136”

    PackageNDC
    Bottle of 1000603-3581-21
    Bottle of 5000603-3581-28

    5 mg Pink, round, 11 mm, marked “E137”

    PackageNDC
    Bottle of 1000603-3582-21
    Bottle of 5000603-3582-28

    10 mg Red, round, 11 mm, marked “E138”

    PackageNDC
    Bottle of 1000603-3583-21
    Bottle of 5000603-3583-28

    Inactive ingredients: calcium silicate, polyoxyl 40 castor oil, hydroxypropyl cellulose (1600000 wamw), hypromelloses, lactose form, cellulose, microcrystalline, propyl gallate, sodium stearyl fumarate, titanium dioxide, triacetin, FD&C Blue No. 2, ferric oxide yellow, ferric oxide red

  • Rising Pharma HoldingsER tablet 2.5 mg, 5 mg, 10 mg

    Has lactose · Has a dye: FD&C Blue No. 2 · Made by Aurobindo Pharma

    How it looks, what’s in it, NDCs

    2.5 mg Green, round, 11 mm, marked “X / 15”

    PackageNDC
    Bottle of 10057237-108-01

    5 mg Pink, round, 11 mm, marked “X / 16”

    PackageNDC
    Bottle of 10057237-109-01

    10 mg Brown, round, 11 mm, marked “X / 17”

    PackageNDC
    Bottle of 10057237-110-01

    Inactive ingredients: silicon dioxide, aluminum silicate, hydroxypropyl cellulose, hypromellose 2910 (50 mpa.s), hypromellose 2208 (100 mpa.s), hypromellose 2910 (6 mpa.s), lactose monohydrate, microcrystalline cellulose, polyethylene glycol 6000, polyoxyl 40 hydrogenated castor oil, propyl gallate, sodium stearyl fumarate, titanium dioxide, FD&C Blue No. 2, ferric oxide yellow, ferric oxide red

    FDA label

  • Torrent PharmaceuticalsER tablet 2.5 mg, 5 mg, 10 mg

    Has lactose · Has a dye: FD&C Blue No. 2

    How it looks, what’s in it, NDCs

    2.5 mg Green, round, 8 mm, marked “32 / 2 / 5”

    PackageNDC
    Bottle of 3013668-132-30
    Bottle of 9013668-132-90
    Bottle of 10013668-132-01
    Bottle of 50013668-132-05
    Bottle of 100013668-132-10

    5 mg Pink, round, 11 mm, marked “33 / 5”

    PackageNDC
    Bottle of 3013668-133-30
    Bottle of 9013668-133-90
    Bottle of 10013668-133-01
    Bottle of 50013668-133-05
    Bottle of 100013668-133-10

    10 mg Reddish Brown, round, 11 mm, marked “34 / 10”

    PackageNDC
    Bottle of 3013668-134-30
    Bottle of 9013668-134-90
    Bottle of 10013668-134-01
    Bottle of 50013668-134-05
    Bottle of 100013668-134-10

    Inactive ingredients: cellulose, microcrystalline, silicon dioxide, FD&C Blue No. 2, ferric oxide yellow, hydroxypropyl cellulose, hypromelloses, lactose, magnesium oxide, polyoxyl 40 hydrogenated castor oil, propyl gallate, propylene glycol, sodium stearyl fumarate, talc, titanium dioxide, ferric oxide red

    FDA label

  • Westminster PharmaceuticalsER tablet 2.5 mg, 5 mg, 10 mg

    Has lactose · Sold as Felopdipine · Made by Pharmobedient Consulting

    Product page on wprx.com

    How it looks, what’s in it, NDCs

    2.5 mg Yellow, round, 11 mm, marked “Y161”

    PackageNDC
    Bottle of 10069367-264-01

    5 mg Pink, round, 11 mm, marked “Y162”

    PackageNDC
    Bottle of 10069367-265-01

    10 mg Red, round, 11 mm, marked “Y163”

    PackageNDC
    Bottle of 10069367-266-01

    Inactive ingredients: anhydrous lactose, butylated hydroxyanisole, butylated hydroxytoluene, silicon dioxide, hypromellose, polyoxyl 40 hydrogenated castor oil, microcrystalline cellulose, povidone k30, sodium stearyl fumarate, ferrosoferric oxide, ferric oxide red, ferric oxide yellow, maltodextrin, medium-chain triglycerides, polydextrose, talc, titanium dioxide

Who sells it: FDA and Medicaid records, updated weekly. Each maker’s page, card and program is from its own site.

What it’s used for

What the FDA label says

Felodipine extended-release tablets, USP are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including felodipine.

Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than 1 drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program's Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC).

Numerous antihypertensive drugs, from a variety of pharmacologic classes and with different mechanisms of action, have been shown in randomized controlled trials to reduce cardiovascular morbidity and mortality, and it can be concluded that it is blood pressure reduction, and not some other pharmacologic property of the drugs, that is largely responsible for those benefits. The largest and most consistent cardiovascular outcome benefit has been a reduction in the risk of stroke, but reductions in myocardial infarction and cardiovascular mortality also have been seen regularly.

Elevated systolic or diastolic pressure causes increased cardiovascular risk, and the absolute risk increase per mmHg is greater at higher blood pressures, so that even modest reductions of severe hypertension can provide substantial benefit. Relative risk reduction from blood pressure reduction is similar across populations with varying absolute risk, so the absolute benefit is greater in patients who are at higher risk independent of their hypertension (for example, patients with diabetes or hyperlipidemia), and such patients would be expected to benefit from more aggressive treatment to a lower blood pressure goal.

Some antihypertensive drugs have smaller blood pressure effects (as monotherapy) in black patients, and many antihypertensive drugs have additional approved indications and effects (eg, on angina, heart failure, or diabetic kidney disease). These considerations may guide selection of therapy.

Felodipine extended-release tablets, USP may be administered with other antihypertensive agents.

Source: the FDA label for Felodipine (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.), August 11, 2026. Full label on DailyMed